TL;DR
Medicare has launched ACCESS, a decade-long program that shifts reimbursement from activity-based to outcome-based payments, explicitly supporting AI-driven healthcare solutions. Most of the tech industry has yet to recognize its implications for AI and healthcare innovation.
Medicare has launched the ACCESS program, a pioneering initiative that creates a new payment pathway explicitly designed to fund AI-driven healthcare solutions, starting July 5, 2024. This development marks a significant shift in federal healthcare reimbursement, with potential implications for AI innovation that most of the tech industry has yet to recognize.
ACCESS, short for Advancing Chronic Care with Effective, Scalable Solutions, is a 10-year CMS initiative testing a payment model that rewards providers for achieving measurable health outcomes rather than performing specific activities. Participating organizations, including startups and healthcare providers, can now receive predictable payments for managing chronic conditions, with full reimbursement contingent on patient health improvements such as lower blood pressure or reduced pain.
This is the first time Medicare has created a reimbursement mechanism that directly funds AI tools used for remote monitoring, patient engagement, or care coordination outside traditional clinical visits. Neil Batlivala, founder of Pair Team, which was accepted into the program, described it as a ‘payment model transformation’ that enables AI to be integrated into care at scale for the first time.
Why It Matters
This development matters because it signals a fundamental change in how healthcare services, especially those driven by AI and digital tools, can be funded and scaled within the federal system. It could accelerate AI adoption in healthcare, improve outcomes for vulnerable populations, and reshape industry standards for reimbursement. However, it also introduces risks related to data security and the financial sustainability of such models, given past mixed results of CMS innovation programs.
Closing the Care Gap with Wearable Devices (Intelligent Health Series)
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
Prior to ACCESS, Medicare reimbursement was primarily activity-based, paying for specific services or time spent with clinicians. The program was designed by former startup founders within CMS to foster innovation through outcome-based payments, emphasizing competition and direct-to-consumer enrollment. The initiative reflects a broader trend toward integrating AI and digital health tools into mainstream healthcare, but most tech companies remain unaware or unprepared for this shift.
Neil Batlivala’s company, Pair Team, has been developing AI-enabled community health models since 2019, focusing on underserved populations with complex social and medical needs. The deployment of Flora, an AI voice agent, exemplifies how AI is already being used to improve patient engagement and reduce hospital visits, which now can be reimbursed directly through ACCESS.
“The government is creating swim lanes for AI innovation in traditionally regulated industries. The best solution wins, which, in regulated industries like healthcare — that’s not been the case.”
— Neil Batlivala
“The program’s design encourages outcome-based competition and direct-to-consumer enrollment, reflecting a startup mindset within federal healthcare.”
— Abe Sutton, CMS Innovation Center director
Artificial Intelligence for Improved Patient Outcomes: Principles for Moving Forward with Rigorous Science
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It remains unclear how widespread AI adoption will become under the new reimbursement model, and whether CMS will sustain or expand this approach after initial testing. Data security concerns persist, especially given the sensitive nature of patient information involved. Additionally, the financial impact on CMS and participating providers remains uncertain, given past mixed results of similar innovation programs.
medicare AI care coordination devices
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
The program officially launches on July 5, 2024. Monitoring will focus on how effectively participating organizations leverage AI tools to improve outcomes and how CMS evaluates the program’s financial and health impacts. Further policy adjustments or expansions could follow based on early results and stakeholder feedback.
Health & Her Perimenopause Supplement for Women – The UK’s No.1 Perimenopause Supplement – Multi-Nutrient Wellbeing Support for Early Stage of Menopause, Vegan, Gluten-Free, Non GMO (60 ct – 1 Month)
AS SEEN ON TV: THE UK'S #1 PERIMENOPAUSE SUPPLEMENT* – Your symptoms and needs during perimenopause are different…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does ACCESS differ from traditional Medicare reimbursement?
ACCESS shifts from paying for specific activities or visits to rewarding organizations for achieving measurable health outcomes, enabling direct funding for AI tools used in care management.
Why is most of the tech industry unaware of this development?
Because it is a recent, specialized federal program with a focus on outcome-based payments and social determinants of health, which has not been widely communicated or understood outside healthcare policy circles.
What types of AI solutions are expected to benefit from this program?
AI tools for remote patient monitoring, virtual engagement, care coordination, and social support are expected to be eligible for reimbursement once integrated into qualifying care models.
What are the risks associated with this new payment model?
Risks include data security concerns, especially given sensitive patient information, and financial sustainability if AI solutions do not demonstrate sufficient health improvements or if reimbursement rates are too low.
What happens if the program succeeds or fails?
If successful, it could lead to broader adoption of outcome-based, AI-enabled care models across Medicare and other payers. Failure could result in program adjustments or discontinuation, with limited immediate impact on the broader healthcare system.
